Picture of Biofil Chemicals and Pharmaceuticals logo

BIOFILCHEM Biofil Chemicals and Pharmaceuticals Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Biofil Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue124231297358224
Cost of Revenue
Gross Profit25.931.443.833.229.2
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses117225283346215
Operating Profit6.386.5714.111.99.05
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes5.885.9814.619.210.1
Provision for Income Taxes
Net Income After Taxes4.714.8212.112.46.98
Net Income Before Extraordinary Items
Net Income4.714.8212.112.46.98
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income4.714.8212.112.46.98
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.2890.2960.7420.7630.429
Dividends per Share

Or unlock with your email

Or unlock with your email